top of page

Investigational Device

Capturing the
Cells that Matter.

OncoMetastat® is an extracorporeal blood-processing platform engineered to selectively capture and deplete circulating tumor cells — designed to delay cancer metastasis in early stage cancers.

OncoMetastat Artwork
GeminiGenerated_Image_nzs47ynzs47ynzs4_edited.jpg

300+

Patients samples processed

94.4%

Sensitivity (vs OncoDiscover®)

9+

Cancer types tested

The OncoMetastat® device

OncoMetastat Device
OncoMetastat® Device 

For research use only. Safety and effectiveness have not been established.

OncoMetastat Display and motor
OncoMetastat® Digital Screen and pump
OncoMetastat Components
OncoMetastat® Components

The OncoMetastat® technology aims to pioneer an innovative, research-driven strategy as a new therapeutic direction in preventing and delaying cancer metastasis.

Know More

Our
Publications

In collaboration with researchers and thought leaders around the world, OncoMetastat® combines scientific expertise with cutting-edge innovation to advance the frontiers of cancer care. The research behind the technology is supported by 100+ scientific publications presented at leading global forums such as ASCO, AACR, ESMO, ISLB, etc

View all publications
asco-logo-header-desktop-580.png
American_Association_for_Cancer_Research_logo.png
logo-ISLB1.png
ESMO_logo_RGB.png

Latest from Actorius

Explore the latest updates, research perspectives, announcements, and stories shaping our work.

View all updates
ASCO 2026 : Association of circulating tumor cells with PD-L1 expression and clusters in confirmative tumor thrombus in selective solid cancers.

17 March 2026

Read More
Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions

17 March 2026

Read More
ASCO 26: Assessment of circulating tumor cells and clusters expressing PD-L1 in urological cancers

17 March 2026

Read More

OncoMetastat® in Action

Stay updated with our latest events, scientific discussions, collaborations, and milestones that continue to shape the future of cancer research and innovation.

View all events
AACR 2026 | Actorius Innovations and Research
Meet us at AACR 2026

21 March 2026

Read More
Meeting with Oncology KOLs in USA | Klaus Pantel , Catherine Alix, Umberto, Ravindra Kolhe
Meeting with our International KOLs

20 February 2026

Read More
Actorius ISLB 2025 | 1-3 November 2025
ISLB 2025 | 1-3 November 2025

3 November 2025

Read More
B&W+1.webp

Be informed.
Be a fighter.

In the News

Explore how OncoMetastat® is making headlines in cancer research,  diagnostics and therapeutics.

View all mentions
Lokmat Times | Actorius Innovations and Research
Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions
Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

17 March 2026

Read More
Business Standards | Actorius Innovations and Research
Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions
Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

17 March 2026

Read More
ANI News | Actorius Innovations and Research
Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions
Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

17 March 2026

Read More
© Copyright Actorius Innovations and Research
bottom of page